Q2 2019 Holdings
Filed 2019-08-13 | 46 holdings | $459.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $237.2M | 2,060,135 | 51.6% |
| Crinetics Pharmaceuticals Inc(CRNX) | Common | 22663K107 | $84.4M | 3,375,169 | 18.3% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $73.3M | 2,765,153 | 15.9% |
| Codexis, Inc(CDXS) | Common | 192005106 | $48.2M | 2,614,458 | 10.5% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $12.6M | 1,913,623 | 2.7% |
| Aclaris Therapeutics, Inc.(ACRS) | Common | 00461U105 | $3.6M | 1,647,214 | 0.8% |
| Tricida, Inc.(1T7) | Common | 89610F101 | $56.2K | 1,424,525 | 0.0% |
| Insmed Inc(INSM) | Common Par | 457669307 | $44.8K | 1,748,174 | 0.0% |
| Iovance Biotherapeutics, Inc.(IOVA) | Common | 462260100 | $39.2K | 1,600,000 | 0.0% |
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $38.2K | 5,900,000 | 0.0% |
| Zymeworks Inc | Common | 98985W102 | $32.0K | 1,453,467 | 0.0% |
| KalVista Pharmaceuticals Inc.(KALV) | Common | 483497103 | $30.1K | 1,359,149 | 0.0% |
| Kadmon Holdings Inc(KDMN) | Common | 48283N106 | $26.0K | 12,606,605 | 0.0% |
| The Medicines Company | Common | 584688105 | $24.4K | 669,012 | 0.0% |
| Menlo Therapeutics Inc. | Common | 586858102 | $24.0K | 4,011,236 | 0.0% |
| Mirati Therapeutics Inc.(MRTXEUR) | Common | 60468T105 | $24.0K | 233,045 | 0.0% |
| Amyris, Inc(AMRSEUR) | Common | 03236M200 | $23.1K | 6,490,557 | 0.0% |
| Homology Medicines, Inc. | Common | 438083107 | $22.7K | 1,159,742 | 0.0% |
| Eiger BioPharmaceuticals Inc(CLDNEUR) | Common | 28249U105 | $19.0K | 1,791,257 | 0.0% |
| Orchard Therapeutics plc | ADS | 68570P101 | $18.4K | 1,312,084 | 0.0% |
| Chiasma Inc(CHMA) | Common | 16706W102 | $17.8K | 2,377,213 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $15.4K | 2,154,934 | 0.0% |
| MEI Pharma Inc | Common | 55279B202 | $14.2K | 5,681,397 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $13.9K | 1,405,476 | 0.0% |
| Soleno Therapeutics, Inc. | Common | 834203200 | $12.0K | 4,268,959 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | Common | 77313F106 | $11.8K | 786,712 | 0.0% |
| Kiniksa Pharmaceuticals | Common | G5269C101 | $11.4K | 843,478 | 0.0% |
| Obseva SA | Common | H5861P103 | $10.6K | 937,147 | 0.0% |
| Nabriva Therapeutics AG | SHS | G63637105 | $9.8K | 4,039,139 | 0.0% |
| Apellis Pharmaceuticals, Inc.(APLS) | Common | 03753U106 | $9.7K | 383,538 | 0.0% |
| Verona Pharma PLC(VRNA) | ADS | 925050106 | $7.6K | 1,492,951 | 0.0% |
| Galmed Pharmaceuticals Ltd(GLMD) | SHS | M47238106 | $7.1K | 971,337 | 0.0% |
| Dermira Inc(DERMEUR) | Common | 24983L104 | $6.7K | 700,000 | 0.0% |
| Kala Pharmaceuticals, Inc. | Common | 483119103 | $6.7K | 1,043,020 | 0.0% |
| Karuna Therapeutics Inc | Common | 48576A100 | $6.5K | 325,000 | 0.0% |
| Matinas Biopharma Hldgs Inc | Common | 576810105 | $5.8K | 6,818,181 | 0.0% |
| Zogenix Inc | Common | 98978L204 | $5.0K | 105,000 | 0.0% |
| Precision Biosciences Inc | Common | 74019P108 | $3.7K | 280,511 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | Common | 372427401 | $2.5K | 626,401 | 0.0% |
| DBV Technologies S.A. | ADR | 23306J101 | $2.2K | 269,995 | 0.0% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common | 00847L100 | $2.2K | 1,513,975 | 0.0% |
| Sierra Oncology, Inc | Common | 82640U107 | $1.4K | 2,438,270 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | Common | 816212104 | $977 | 546,054 | 0.0% |
| Akari Therapeutics Plc | ADR | 00972G108 | $699 | 345,850 | 0.0% |
| BioPharmX Corporation | Common | 09072X309 | $189 | 317,270 | 0.0% |
| Soleno Therapeutics, Inc. - Warrant | Warrant | 834203135 | $19 | 188,772 | 0.0% |